STOCK TITAN

Lionsgate director granted 13,405 RSUs, 5,362 shares

A Lionsgate Studios Corp. director received equity awards and share-settled fees, increasing her direct stake through stock-based compensation.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lionsgate Studios Corp. (LION) director Yvette Ostolaza reported two equity-related acquisitions of common shares on September 15, 2026. She received 13,405 common shares at $0.00 per share as an annual director equity award, structured as restricted share units that are scheduled to vest on September 15, 2027. She also acquired 5,362 common shares at $11.19 per share as director fees paid in common shares, with all such awards and units held directly and no Rule 10b5-1 trading plan reported.

Positive

  • None.

Negative

  • None.
Insider Ostolaza Yvette
Role Director
Type Security Shares Price Value
Grant/Award Common Shares F1, F2 13,405 $0.00 $0.00
Grant/Award Common Shares F3, F2 5,362 $11.19 $60K
Holdings After Transaction: Common Shares — 166,587 shares (Direct)
Footnotes (3)
  1. F1. Annual director equity award.
  2. F2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
  3. F3. Director fees paid in common shares.
Annual director equity award 13,405 shares Common shares granted to Yvette Ostolaza on September 15, 2026 at $0.00 per share
Director fees paid in common shares 5,362 shares Common shares issued to Yvette Ostolaza on September 15, 2026 at $11.19 per share
Price per share for share-settled director fees $11.19 per share Applied to 5,362 common shares issued as director fees
RSUs vesting November 28, 2026 20,107 restricted share units RSUs held by Yvette Ostolaza, payable in an equal number of common shares upon vesting
RSUs vesting September 15, 2027 13,405 restricted share units RSUs held by Yvette Ostolaza, matching the annual director equity award grant
restricted share units financial
"restricted share units granted by the Issuer, payable upon vesting"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
annual director equity award financial
"Annual director equity award."
director fees paid in common shares financial
"Director fees paid in common shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Lionsgate Studios Corp. (LION) report for Yvette Ostolaza?

On September 15, 2026, director Yvette Ostolaza reported two acquisitions of common shares: an annual director equity award and shares received as director fees paid in common shares, all held as direct ownership.

How many Lionsgate Studios (LION) shares were granted as an annual director equity award?

Yvette Ostolaza received 13,405 common shares as an annual director equity award. These are in the form of restricted share units that are scheduled to vest on September 15, 2027, and will be payable in an equal number of common shares upon vesting.

What portion of Lionsgate Studios (LION) director compensation was paid in stock on September 15, 2026?

On September 15, 2026, 5,362 common shares of Lionsgate Studios Corp. were issued to director Yvette Ostolaza as director fees paid in common shares, at a reported price of $11.19 per share.

When do Yvette Ostolaza’s Lionsgate Studios (LION) restricted share units vest?

The filing states that restricted share units held by Yvette Ostolaza include 20,107 RSUs scheduled to vest on November 28, 2026 and 13,405 RSUs scheduled to vest on September 15, 2027, each payable in an equal number of common shares upon vesting.

Were Yvette Ostolaza’s Lionsgate Studios (LION) equity transactions under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote indicating that the September 15, 2026 equity awards or fee payments were made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ostolaza Yvette

(Last)(First)(Middle)
LIONSGATE
2700 COLORADO AVENUE

(Street)
SANTA MONICA CALIFORNIA 90404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares09/15/2026A13,405(1)A$0161,225(2)D
Common Shares09/15/2026A5,362(3)A$11.19166,587(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Annual director equity award.
2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
3. Director fees paid in common shares.
Remarks:
Yvette Ostolaza (By Adrian Kuzycz by Power of Attorney)09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading